HEAL-IST IDE Trial

Inappropriate Sinus Tachycardia Clinical Trial

Official title:
Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia

Status Recruiting

Clinical Trial Summary

Inappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective of this clinical trial is to evaluate the safety and effectiveness of a hybrid sinus node sparing ablation procedure for the treatment of symptomatic drug refractory or drug intolerant IST.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05280093
Study type	Interventional
Source	AtriCure, Inc.
Contact	Joseph Derr
Phone	1 (866) 349-2342
Email	jderr@atricure.com
Status	Recruiting
Phase	N/A
Start date	May 31, 2022
Completion date	June 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01657136` - Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia	Phase 3
Recruiting	`NCT03317249` - Pregnancy Related Inappropriate Sinus Tachycardia
Recruiting	`NCT05107635` - Inappropriate Sinus Tachycardia Registry
Recruiting	`NCT02018497` - Essential Hypotension and Allostasis Registry
Withdrawn	`NCT01695538` - Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes	N/A
Terminated	`NCT00584649` - Ablation of Inappropriate Sinus Tachycardia	N/A